Exicure, Inc. (XCUR) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Exicure, Inc. (XCUR) closed at USD 1.21 on 2026-10-14, a change of -73.5 % over the past year, with a market capitalization of USD 7.33M.

Exicure, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Exicure, Inc. key figures

Previous close

USD 1.21 (2026-10-14)

1-year change

-73.5 %

Market cap

USD 7.33M

Enterprise value

USD 5.61M

P/E ratio (trailing)

-0.86

P/E ratio (forward)

-1.46

EPS (trailing)

-1.31

EPS (forward)

-0.77

PEG ratio

n/a

Price to book

3.40

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

1.22

Employees

1

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Exicure, Inc.

Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Exicure, Inc. and compare it with other stocks.